Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Cell Cycle. 2012 Sep 1;11(17):3199-210. doi: 10.4161/cc.21281. Epub 2012 Aug 16.
Mammalian genomes contain thousands of cis-regulatory elements for each transcription factor (TF), but TFs only occupy a relatively small subset referred to as cistrome. Recent studies demonstrate that a TF cistrome might differ among different organisms, tissue types and individuals. In a cell, a TF cistrome might differ among different physiological states, pathological stages and between physiological and pathological conditions. It is, therefore, remarkable how highly plastic these binding profiles are, and how massively they can be reprogrammed in rapid response to intra/extracellular variations and during cell identity transitions and evolution. Biologically, cistrome reprogramming events tend to be followed by changes in transcriptional outputs, thus serving as transformative mechanisms to synchronically alter the biology of the cell. In this review, we discuss the molecular basis of cistrome plasticity and attempt to integrate the different mechanisms and biological conditions associated with cistrome reprogramming. Emerging data suggest that, when altered, these reprogramming events might be linked to tumor development and/or progression, which is a radical conceptual change in our mechanistic understanding of cancer and, potentially, other diseases.
哺乳动物基因组包含数千个转录因子 (TF) 的顺式调控元件,但 TF 只占据相对较小的一部分,称为顺式组。最近的研究表明,TF 的顺式组在不同的生物体、组织类型和个体之间可能存在差异。在一个细胞中,TF 的顺式组可能在不同的生理状态、病理阶段以及生理和病理条件之间存在差异。因此,这些结合谱的高度可塑以及它们如何能够在快速响应细胞内/外变化以及在细胞身份转变和进化过程中进行大规模重编程是非常显著的。从生物学角度来看,顺式组重编程事件往往伴随着转录输出的变化,因此作为一种变革性机制,同步改变细胞的生物学特性。在这篇综述中,我们讨论了顺式组可塑性的分子基础,并试图整合与顺式组重编程相关的不同机制和生物学条件。新出现的数据表明,当这些重编程事件发生改变时,它们可能与肿瘤的发生和/或进展有关,这是我们对癌症以及潜在的其他疾病的机制理解的一个根本性概念上的改变。